Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How business is dealing with the AIDS epidemic.

V Gerson

    Business and Health
    |December 8, 1996
    PubMed
    Summary

    Despite fears of high costs, employers did not face a surge in human immunodeficiency virus (HIV)-related claims. Innovative company strategies are emerging as treatments improve patient outlooks and raise expenses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Core histone N-termini play an essential role in mitotic chromosome condensation.

    The EMBO journal·2000
    Same author

    The changing face of case management.

    Healthplan·1997
    Same author

    Pinning down the value of premier benefits.

    Business and health·1997
    Same author

    Are we squeezing the life out of hospitals?

    The state of health care in America·1996
    Same author

    Chomping at the health care system.

    Business and health·1996
    Same author

    Incentive programs prove rewarding for employees who earn recognition. Injury and workers' compensation cost reductions are possible through cash or gift prizes.

    Occupational health & safety (Waco, Tex.)·1994

    Area of Science:

    • Public Health
    • Occupational Health
    • Health Economics

    Background:

    • Employers anticipated significant financial burdens due to human immunodeficiency virus (HIV)-related healthcare claims.
    • The advent of new treatments has altered the prognosis for individuals with HIV, potentially impacting long-term care costs.

    Purpose of the Study:

    • To analyze the actual trend of HIV-related claims experienced by employers.
    • To identify and evaluate innovative strategies implemented by companies to manage HIV-related costs and employee health.
    • To provide insights into effective approaches for employers facing evolving HIV treatment landscapes.

    Main Methods:

    • Review of employer claims data related to HIV.
    • Analysis of cost trends associated with HIV treatment and management.
    • Case studies of forward-thinking companies and their implemented strategies.

    Main Results:

    • The anticipated "avalanche" of astronomical HIV-related claims did not materialize for most employers.
    • New HIV treatments are improving patient prognoses but also increasing overall treatment costs.
    • Several companies have developed and implemented innovative strategies to manage these evolving costs and support employees.

    Conclusions:

    • Employer experiences with HIV-related claims have been less severe than initially feared.
    • Proactive and innovative strategies are crucial for employers to effectively manage the costs and health outcomes associated with HIV.
    • The findings offer valuable lessons for corporate health benefit planning and management in the context of advancing medical treatments.

    Related Experiment Videos